Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Agilent Technology Q4 Earnings Improve, Expects 6% To 8% Revenue Growth In Q1 - Nasdaq
Agilent Technology Q4 Earnings Improve, Expects 6% To 8% Revenue Growth In Q1 Nasdaq
Top Stock Reports for Alphabet, Roche & RTX - Nasdaq
Top Stock Reports for Alphabet, Roche & RTX Nasdaq
10x Genomics (TXG) Price Target Increased by 10.47% to 16.66 - Nasdaq
10x Genomics (TXG) Price Target Increased by 10.47% to 16.66 Nasdaq
There's Reason For Concern Over 10x Genomics, Inc.'s (NASDAQ:TXG) Massive 42% Price Jump - simplywall.st
There's Reason For Concern Over 10x Genomics, Inc.'s (NASDAQ:TXG) Massive 42% Price Jump simplywall.st
10x Genomics (NASDAQ:TXG) Nasdaq Futures Drives Data Biology - Kalkine Media
10x Genomics (NASDAQ:TXG) Nasdaq Futures Drives Data Biology Kalkine Media
Piper Sandler Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq
Piper Sandler Maintains 10x Genomics (TXG) Neutral Recommendation Nasdaq
Illumina, Inc. (NASDAQ:ILMN) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected - simplywall.st
Illumina, Inc. (NASDAQ:ILMN) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected simplywall.st
10x Genomics, Inc. (NASDAQ:TXG) Q3 2025 Earnings Call Transcript - Insider Monkey
10x Genomics, Inc. (NASDAQ:TXG) Q3 2025 Earnings Call Transcript Insider Monkey
Barclays Maintains 10x Genomics (TXG) Overweight Recommendation - Nasdaq
Barclays Maintains 10x Genomics (TXG) Overweight Recommendation Nasdaq
JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq
JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation Nasdaq
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Markets Financial Content
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% Markets Financial Content
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - Nasdaq
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates Nasdaq
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics - Nasdaq
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics Nasdaq
10x Genomics (NASDAQ: TXG) guides fourth‑quarter revenue to $154–$158M after results - Stock Titan
10x Genomics (NASDAQ: TXG) guides fourth‑quarter revenue to $154–$158M after results Stock Titan
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Yahoo Finance
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% Yahoo Finance
Barclays Maintains Illumina (ILMN) Underweight Recommendation - Nasdaq
Barclays Maintains Illumina (ILMN) Underweight Recommendation Nasdaq
Illumina (NASDAQ:ILMN) Beats Q3 Sales Expectations - Yahoo Finance
Illumina (NASDAQ:ILMN) Beats Q3 Sales Expectations Yahoo Finance
Thermo Fisher Scientific Q3 Profit Beats Estimates - Nasdaq
Thermo Fisher Scientific Q3 Profit Beats Estimates Nasdaq